Madrigal Pharmaceuticals (MDGL) EBT Margin (2010 - 2026)

Madrigal Pharmaceuticals (MDGL) reported EBT Margin of 29.64% for Q1 2026, up 2372.0% year-over-year from 1.2% in Q1 2025, and down 62.83% quarter-over-quarter from 18.2% in Q4 2025.

Madrigal Pharmaceuticals (MDGL) EBT Margin (2010 - 2026) Analysis & Trends

Madrigal Pharmaceuticals (MDGL) has 6 years of EBT Margin data on file, last reported at 29.64% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 29.64%, up 2372.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 26.85% (up 9653.0% YoY), and the FY2025 annual result was 29.74%, up 22890.0% from the prior year.
  • EBT Margin retreated to 29.64% in Q1 2026 per MDGL's latest filing, from 18.2% in the prior quarter.
  • Over five years, EBT Margin peaked at 18.2% in Q4 2025 and troughed at 1038.2% in Q2 2024.
  • A 3-year average of 178.43% and a median of 46.02% in 2025 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin surged 101835 bps in 2025, then surged 2372 bps in 2026.
  • A 3-year view of EBT Margin shows it stood at 57.51% in 2024, then soared by 68 bps to 18.2% in 2025, then plunged by 63 bps to 29.64% in 2026.
  • Business Quant data shows MDGL's EBT Margin at 29.64% in Q1 2026, 18.2% in Q4 2025, and 38.68% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Madrigal Pharmaceuticals 14.67 Bn 14.44 Bn - -29.64%

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.64%
Dec 31, 2025 -18.20%
Sep 30, 2025 -38.68%
Jun 30, 2025 -19.85%
Mar 31, 2025 -53.36%
Dec 31, 2024 -57.51%
Sep 30, 2024 -172.04%
Jun 30, 2024 -1,038.20%
Mar 31, 2012 -10,238.78%
Dec 31, 2011 -313.85%
Sep 30, 2011 -2,444.15%
Jun 30, 2011 -5,925.12%
Mar 31, 2011 -997.46%
Dec 31, 2010 -218.55%
Sep 30, 2010 -303.34%
Jun 30, 2010 -270.06%